INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹565 Cr | ₹611 Cr | ₹489 Cr | ₹440 Cr | ₹199 Cr |
What is the latest Total Current Liabilities ratio of INDEGENE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹565 Cr |
| Mar2024 | ₹611 Cr |
| Mar2023 | ₹489 Cr |
| Mar2022 | ₹440 Cr |
| Mar2021 | ₹199 Cr |
How is Total Current Liabilities of INDEGENE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹565 Cr | -7.60 | |
| Mar2024 | ₹611 Cr | 24.90 | |
| Mar2023 | ₹489 Cr | 11.05 | |
| Mar2022 | ₹440 Cr | 120.85 | |
| Mar2021 | ₹199 Cr | - | |
Compare Total Current Liabilities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹10,662.6 Cr | -3.5% | -8.8% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -3.5% |
-8.8% |
-14.6% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses